trending Market Intelligence /marketintelligence/en/news-insights/trending/QIudGb-Z9GlsnvwMin2S5A2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

ResTORbio plans $50M common stock offering

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


ResTORbio plans $50M common stock offering

Biopharmaceutical company resTORbio Inc. started an underwritten public offering of $50 million of its common shares.

Underwriters will have an option to buy up to an additional 15% of shares in the public offering to cover overallotments.

BofA Merrill Lynch, SVB Leerink and Guggenheim Securities are acting as joint book-running managers with Wedbush PacGrow acting as co-manager for the proposed offering.

Boston-based resTORbio develops and sells novel therapeutics to treat aging-related diseases.